Cargando…
Efavirenz Dissolution Enhancement I: Co-Micronization
AIDS constitutes one of the most serious infectious diseases, representing a major public health priority. Efavirenz (EFV), one of the most widely used drugs for this pathology, belongs to the Class II of the Biopharmaceutics Classification System for drugs with very poor water solubility. To improv...
Autores principales: | da Costa, Maíra Assis, Seiceira, Rafael Cardoso, Rodrigues, Carlos Rangel, Hoffmeister, Cristiane Rodrigues Drago, Cabral, Lucio Mendes, Rocha, Helvécio Vinícius Antunes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834943/ https://www.ncbi.nlm.nih.gov/pubmed/24300394 http://dx.doi.org/10.3390/pharmaceutics5010001 |
Ejemplares similares
-
Influence of the Efavirenz Micronization on Tableting and Dissolution
por: Pinto, Eduardo Costa, et al.
Publicado: (2012) -
Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans
por: Pupe, Carolina Gonçalves, et al.
Publicado: (2011) -
Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques
por: Madhavi, B. Bindu, et al.
Publicado: (2011) -
Dissolution and pharmacokinetics of a novel micronized aspirin formulation
por: Voelker, M., et al.
Publicado: (2011) -
Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
por: Koh, P. T., et al.
Publicado: (2013)